Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/2010
06/17/2010US20100151003 Egfr binding peptides and uses thereof
06/17/2010US20100150957 Peptides for active anti-cytokine immunization
06/17/2010US20100150929 Peptide Associated with Rheumatic Fever (PARF) and Its Use as a Diagnostic Marker
06/17/2010US20100150904 Binding members for ige molecules
06/17/2010US20100150843 Peptide imaging agents
06/17/2010CA2749558A1 Single-chain antiparallel coiled coil proteins
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010CA2746070A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
06/16/2010EP2196209A1 Ctl inducer composition
06/16/2010EP2195331A2 Synthetic apolipoprotein e mimicking polypeptides and methods of use
06/16/2010EP2195329A2 Methods and intermediates for chemical synthesis of polypeptides and proteins
06/16/2010CN1812997B Pharmaceutical composition outside stomach intestine containing somatostatin analogue
06/16/2010CN1518558B Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament
06/16/2010CN101735309A Iridovirus antigen active polypeptide and application thereof
06/16/2010CN101735308A Synthesizing method of buserelin
06/16/2010CN101735307A Platelet envelope glycoprotein oligopeptide or trim/derivate thereof and application thereof
06/15/2010US7737252 Peptide-based compounds
06/15/2010US7737250 Peptides for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons
06/15/2010US7737114 macrocyclic depsipeptides, for use as anticancer agents and an inhibitors of protein synthesis, cell growth, and tumorigenesis and as enhancers of apoptosis
06/15/2010US7737113 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others
06/15/2010US7737111 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
06/15/2010US7736659 Clostridial toxin derivatives and methods for treating pain
06/15/2010CA2402219C Novel echinocandin derivatives, preparation method and use thereof as fungicides
06/15/2010CA2295940C Epitopes of shigella like toxin and their use as vaccine and in diagnosis
06/10/2010WO2010065815A2 Mini-hepcidin peptides and methods of using thereof
06/10/2010WO2010065568A2 METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
06/10/2010WO2010064430A1 Wdrpuh epitope peptides and vaccines containing the same
06/10/2010WO2010064219A1 Process for the preparation of a novel intermediate for caspofungin
06/10/2010WO2010063124A1 Peptide therapeutic conjugates and uses thereof
06/10/2010WO2010063123A1 Leptin and leptin analog conjugates and uses thereof
06/10/2010WO2010063122A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
06/10/2010WO2010021961A3 Improved production of proteins with downstream box fusions in plastids and in bacteria
06/10/2010WO2010014616A3 Prominin-1 peptide fragments and uses thereof
06/10/2010WO2010000592A3 Cyclopeptides used as mmp-type protease enzyme inhibitors
06/10/2010US20100145012 Anti-cancer bioactive peptide
06/10/2010US20100145009 Antibodies which are directed against the marburg i polymorphism of factor vii-activating protease (fsap), and their preparation and use
06/10/2010US20100144641 Compositions Having Antiangiogenic Activity and Uses Thereof
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144623 C-Terminal Domain Truncation of mGluR1a By Calpain and Uses Thereof
06/10/2010US20100144607 Anti-inflammatory and antiallergic cyclic peptides
06/10/2010US20100144058 B-lymphocyte stimulator binding polypeptides and methods based thereon
06/10/2010US20100144025 Hla-binding peptide, precursor thereof, dna fragment and recombinant vector encoding the same
06/10/2010US20100143927 Methods and Assays for Measuring p95 and/or p95 in a Sample and Antibodies Specific for p95
06/10/2010US20100143374 Diagnostic and therapeutic target for autoimmune diseases and uses thereof
06/10/2010US20100143352 Combination therapy for b cell disorders
06/10/2010US20100143335 Treating atherosclerosis
06/10/2010US20100143310 SPINAL NERVE REPAIR PROMOTING THERAPEUTICS CONTAINING GHRELIN OR ITS DERIVATIVES OR SUBSTANCES THAT ACT ON GHS-R1a AS AN ACTIVE INGREDIENT
06/10/2010US20100143308 Akt nucleic acids, polypeptides, and uses thereof
06/10/2010US20100143292 Il-21 variants
06/10/2010US20100143262 Method for Identifying Allergenic Proteins And Peptides
06/10/2010US20100143250 Compounds for the diagnosis of apoptosis
06/10/2010DE102008060549A1 Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung Drug-peptide construct for extracellular accumulation
06/10/2010CA2745923A1 Sparc binding scfvs
06/10/2010CA2745527A1 Leptin and leptin analog conjugates and uses thereof
06/10/2010CA2745524A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
06/10/2010CA2745408A1 Wdrpuh epitope peptides and vaccines containing the same
06/09/2010EP2194383A1 Monitoring immunologic, hematologic and inflammatory diseases
06/09/2010EP2194062A1 Cyclic heptapeptide and use of the same
06/09/2010EP1730110B1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
06/09/2010EP1558649B1 Peptid modulating caspase activation
06/09/2010CN1744909B Orally administered peptides synergize statin activity
06/09/2010CN101730708A stitched polypeptides
06/09/2010CN101724026A Melanocortin analogue as well as preparation method and application thereof
06/09/2010CN101724025A Anti-tumor toad polypeptide and preparation method and application thereof
06/09/2010CN101724024A Polypeptide combined with immune antibody and application thereof
06/09/2010CN101724023A Restricted epitope peptide of antigen of mycobacterium tuberculosis
06/09/2010CN101724022A inhibitors of serine proteases, particularly hcv ns3-ns4a protease
06/09/2010CN101724021A Polypeptide conjugates of taxol or docetaxel
06/09/2010CN101724020A Immunological contraception target universal for mammals and specific antibody thereof
06/09/2010CN101724019A Thymopeptide-5 active esters, medicinal composition containing same and application thereof
06/09/2010CN101721676A Gene regulatory peptides
06/08/2010US7732568 Methods for preventing and treating Alzheimer's disease
06/08/2010US7732566 a protein originating from latex that can induce an allergic reaction in persons sensitized to the protein
06/08/2010US7732412 Methods of treatment using novel LHRH antagonists having improved solubility properties
06/08/2010US7731995 Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal
06/08/2010US7731970 Variants of the major allergen Phl p 1 from timothy grass
06/08/2010CA2289916C A novel strain of bacillus for controlling plant diseases and corn rootworm
06/08/2010CA2158047C Allergenic protein and peptides from house dust mite and uses therefor
06/03/2010WO2010062264A1 Lipopeptide compounds and their use
06/03/2010WO2010062217A1 Agent for eliminating multidrug resistance
06/03/2010WO2010062159A1 Bioactive compounds
06/03/2010WO2010061924A1 Avian influenza vaccine
06/03/2010WO2010061919A1 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
06/03/2010WO2010061915A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
06/03/2010WO2010060497A1 A nonapeptide with anti-tumour activity
06/03/2010WO2010060479A1 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
06/03/2010WO2010060218A1 A composition for use as a peptide retention standard and a method of predicting peptide hydrophobicity in liquid chromatography
06/03/2010WO2010060155A1 Compositions and methods for treatment of celiac disease
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137561 Process for preparing therapeutic peptide
06/03/2010US20100137560 Oligopeptides and their use in cosmetics
06/03/2010US20100137559 Process for production of cyclic peptides
06/03/2010US20100137557 Use of one or more metal carriers to selectively kill mammalian cells
06/03/2010US20100137227 Methods and compositions for treating conditions
06/03/2010US20100137223 Neuropeptide-2 receptor (y-2r) agonists and uses thereof
06/03/2010US20100137221 Peptides that interact with topoisomerase i and methods thereof
06/03/2010US20100137220 Blood sugar-modulating polypeptides
06/03/2010US20100137219 Methods and Compositions for Inhibiting Binding IgE to a High Affinity Receptor
06/03/2010US20100137207 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting g protein coupled receptors using the same
06/03/2010US20100137199 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 423